You are here

patents

Merck notches another win in India patent battle over diabetes bestsellers

Fierce Pharma

Wed, 10/7/15 - 09:53 pm

Amgen Turning the Tables on 'Generic' Competition

Motley Fool

Wed, 10/7/15 - 09:59 am

Wall Street Journal Surprised That Pharma Cos Make Out Like Bandits From Patent System

Forbes

Tue, 10/6/15 - 08:16 am

Drugmaker Tactic to Block Generics May Violate Law, FTC Says

Bloomberg

Thu, 10/1/15 - 05:33 pm

Hedge fund manager Kyle Bass escapes sanctions in drug patent case

Yahoo/Reuters

Mon, 09/28/15 - 06:11 pm

Sanofi says reaches patent deal with Eli Lilly on Lantus SoloSTAR

Yahoo/Reuters

Mon, 09/28/15 - 10:13 am

Lantus SoloSTAR

Shire chalks up victory in Vyvanse patent battle

Fierce Pharma

Fri, 09/25/15 - 08:47 pm

Amgen Wants Patent Dance Redo and a Halt to Hospira’s EPOGEN Biosimilar

FDA Law Blog

Thu, 09/24/15 - 09:01 am

Biotech CEO: Bass exploiting weakness in system

CNBC

Sun, 09/20/15 - 12:49 pm

Pfizer loses UK patent case over use of Lyrica drug in pain

Yahoo/Reuters

Thu, 09/10/15 - 06:02 pm

Gilead Sciences Ready To Face Complera Patent War With Mylan

Bidness, ETC

Thu, 09/10/15 - 10:17 am

Allergan sews up a Namenda XR cushion with Amneal patent settlement

Fierce Pharma

Thu, 09/10/15 - 09:47 am

Bass Vows to Keep Fighting U.S. Drug Patents After Setbacks

Bloomberg

Thu, 09/3/15 - 06:34 pm

Acorda Therapeutics

Biogen patent survives challenge by hedge fund manager Kyle Bass

Yahoo/Reuters

Wed, 09/2/15 - 05:14 pm

Acorda Therapeutics

Pharma lobbies Congress for big—and expensive—changes to patent rules

BioPharma Dive

Wed, 09/2/15 - 05:12 pm

pharma industry

Analysts at Merrill Lynch believe Mylan’s patent challenge will not have a negative impact on Teva

Bidness, ETC

Fri, 08/28/15 - 08:02 am

Teva Pharmaceutical

multiple sclerosis

U.S. patent office puts new Copaxone's IP shield under the lens

Fierce Pharma

Wed, 08/26/15 - 08:28 pm

intellectual property

multiple sclerosis

Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patent

NASDAQ.com

Wed, 08/26/15 - 08:50 am

Teva Pharmaceutical

Hedge fund manager Kyle Bass loses first challenges to pharma patents

Yahoo/Reuters

Tue, 08/25/15 - 08:37 am

Acorda Therapeutics

multiple sclerosis

U.S. court shaves 5 years off Velcade patent protection, generics could hit in 2017

Fierce Pharma

Mon, 08/24/15 - 11:36 am

Teva Pharmaceutical

Pages